Publications

Manuscript supplementary materials

  • Journal article: Irazabal, Maria V., M.D., et al. Imaging classification of ADPKD: A simple model for selecting patients for clinical trials. Journal of the American Society of Nephrology. In press.
  • Calculator: Classification of Typical ADPKD Calculator

Archives

2010 publications

Faculty members of the Mayo Translational Polycystic Kidney Disease (PKD) Center published these journal articles in 2011-2012:

  • Bakeberg JL, Tammachote R, Woollard JR, Hogan MC, Tuan HF, Li M, van Deursen JM, Wu Y, Huang BQ, Torres VE, Harris PC, Ward CJ. Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of fibrocystin. Journal of the American Society of Nephrology. 2011;22:2266.
  • Irazabal MV, Huston J 3rd, Kubly V, Rossetti S, Sundsbak JL, Hogan MC, Harris PC, Brown RD Jr, Torres VE. Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology. 2011;6:1274.
  • Irazabal MV, Torres VE, Hogan MC, Glockner J, King BF, Ofstie TG, Krasa HB, Ouyang J, Czerwiec FS. Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease. Kidney International. 2011;80:295.
  • Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navix G, Rodby R, Torres VE, Zhang YL, Greene T, Levey AS. Equations to estimate creatine excretion rate: The CKD epidemiology collaboration. Clinical Journal of the American Society of Nephrology. 2011;6:184.
  • Mason SB, Lai X, Ringham HN, Bacallao RL, Harris PC, Witzmann FA, Gattone VH 2nd. Differential expression of renal proteins in rodent model of Meckel syndrome. Nephron: Experimental Nephrology. 2011;117:e31.
  • Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Masyuk AI, Gradilone SA, Gajdos GB, Chandok N, Bakeberg JL, Ward CJ, Ritman EL, Kiyokawa H, Larusso NF. Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease. Gastroenterology. 2012;142:622.
  • Nagorney DM, Schnelldorfer T, Torres VE, Rosen CB. Resection and fenestration for symptomatic polycystic liver disease. Annals of Surgery. In press. Accessed March 6, 2012.
  • Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT; HALT PKD Study Group, Meyers CM. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology. 2011;6:2508.
  • Ryu JH, Hartman TE, Torres VE, Decker PA. Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas. Chest. 2012;141:163.
  • Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, Hogan MC, Oskoui FR, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin DR, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Meyers CM, Schrier RW. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney International. 2012;81:577.
  • Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr, Wetzel LH, Martin D, Lockhart ME, Bennett WM, Moxey-Mims M, Abebe KZ, Lin Y, Bost JE. Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology. 2011;6:640.
  • Torres VE, Harris PC. Polycystic kidney disease in 2011: Connecting the dots toward a polycystic kidney disease therapy. Nature Reviews Nephrology. 2011;8:66.
  • Torres VE, Meijer E, Bae KT, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang JJ, Czerwiec FS. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. American Journal of Kidney Diseases. 2011;57:692.
  • Ward CJ, Wu Y, Johnson RA, Woollard JR, Bergstralh EJ, Cicek MS, Bakeberg J, Rossetti S, Heyer CM, Petersen GM, Lindor NM, Thibodeau SN, Harris PC, Torres VE, Hogan MC, Boardman LA. Germline PKHD1 mutations are protective against colorectal cancer. Human Genetics. 2011;129:345.